Conference Presentation, Panel
Diabetes and Obesity: An Urgent Global Health Crisis
- Diabetes and obesity prevalence is projected to rise significantly, with China potentially reaching 70% diabetic or pre-diabetic by 2030, North America increasing by 35% to 62 million cases between 2017 and 2045, and the MENA region expected to surge 110% to approximately 82 million.
- Risk factors are identified as the spread of Western diets and lifestyles into the Middle East, urban living versus rural residence, and specific regional patterns where the Middle East and Africa will see continued growth while the U.S. South remains at high levels of type 1 and type 2 diabetes.
- Biological challenges include metabolic adaptation where weight loss triggers hunger hormones to rise and satiety hormones to fall, and genetic factors in the UAE that may decouple obesity rates from sugar consumption compared to the U.S., alongside new interventions targeting gut flora.
- Treatment and care gaps are highlighted by only 40% of those with obesity and 33% of those with overweight receiving care in the U.S., with just 1% of the population struggling with the disease accessing treatment, making employer coverage difficult due to an average job tenure of 2.8 years.
- Future healthcare strategies emphasize team-based patient engagement, lifelong dietary adherence rather than temporary fixes, and potential legislative outcomes where the Treat and Reduce Obesity Act (TROA) could enable 90% of type 2 diabetes patients to receive care by 2025.
- Economic and operational forecasts suggest a need for sustained investment, such as a goal for every U.S. child to enter kindergarten at a healthy weight within six years via a billion-dollar investment, while the UAE government faces a sustainability issue regarding the cost of injectable weight loss medications if usage covers half the population.
- Organizational and technological expectations include the Alliance for a Healthier Generation requiring a budget increase from approximately $20 million to between $50 million and $150 million for scale, alongside a strategic shift toward technology engagement and social emotional learning to counteract one-dimensional digital environments.
- Clinical outcomes anticipate that losing 15 kilograms can induce remission in 50% of patients, achieved through medication, surgery, or new gut flora interventions, though a perfect world scenario would require actual cures for both diabetes and obesity.